Infection and thyroid autoimmunity: A seroepidemiologic study of TPOaAb

References

• Infection and autoimmunity, Y Schoenfeld, NR Rose. Elsevier, Amsterdam 2005
   Google Scholar
• Christen U, von Herrath MG. Infections and autoimmunity—Good or bad?. J Immunol 2005; 174: 7481–7486
   PubMedGoogle Scholar
• Rose NR, Rasooly L, Saboori AM, et al. Linking iodine with autoimmune thyroiditis. Environ Health Perspect 1999; 107(Suppl. 5)749–752
   PubMedGoogle Scholar
• Gartner R, Gasnier BC, Dietrick JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002; 87: 1687–1691
   PubMed Web of Science ®Google Scholar
• Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 605–618
   Google Scholar
• Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocrine Rev 1993; 14(1)107–120
   PubMed Web of Science ®Google Scholar
• Lehmann HW, Lutterbüse N, Plentz A, et al. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol 2008; 21(3)379–383
   PubMed Web of Science ®Google Scholar
• Sterzl I, Hrda P, Matucha P. Anti-helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulinand anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008; 57(s1)S135–S141
   Google Scholar
• Strieder TGA, Wenzel BE, Prummel MF, et al. Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease. Clin Exp Immunol 2003; 132: 278–282
   PubMedGoogle Scholar
• Zöphel K, Saller B, Wunderlich G, Grüning T, Koch R, Wilde J, Mann K, Franke WG. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: Implications for the definition of TPOAb reference intervals. Clin Lab 2003; 49(11–12)591–600
   PubMedGoogle Scholar
• Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol (Oxf) 1977; 7: 481–493
   PubMed Web of Science ®Google Scholar
• Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55–68
   PubMed Web of Science ®Google Scholar
• Wasserman EE, Nelson K, Rose NR, Eaton W, Pillion JP, Seaberg E, Talor MV, Burek L, Duggan A, Yolken RH. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: An epidemiologic assessment. Am J Epidem 2007; 167(4)701–710
   PubMedGoogle Scholar
• Pinard JA, Leslie NS, Irvine PJ. Maternal serologic screening for toxoplasmosis. J Midwifery Women's Health 2003; 48(5)308–315
   PubMedGoogle Scholar
• Gras L, Gilbert RE, Wallon M, Peyron F, Corina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004; 132: 541–548
   PubMed Web of Science ®Google Scholar
• Petersen E. Toxoplasmosis. Fetal Neonat Med 2007; 12: 214–223
   PubMed Web of Science ®Google Scholar
• Eskild A, Bruu AL, Stray-Pedersen B, Jenum P. Epstein–Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. BJOG 2005; 112: 1620–1624
   PubMedGoogle Scholar
• Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA. BMJ 2006, doi: 10.1136/bmj.38668.616808.3A
   Google Scholar
• Avgil M, Ornoy A. Herpes simplex virus and Epstein–Barr virus infections in pregnancy: Consequences of neonatal or intrauterine infection. Repro Toxicol 2006; 21: 436–445
   PubMed Web of Science ®Google Scholar
• Svahn A, Berggren J, Parke A, Storsaeter J, et al. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9–12 years. J Clin Virol 2006; 37(2)118–123
   PubMedGoogle Scholar
• Crowcroft NS, Vyse A, Brown DWG, Strachan DP. Epidemiology of Epstein–Barr virus infection in pre-adolescent children: Application of a new salivary method in Edinburgh, Scotland. J Epidemiol Commun Health 1998; 52: 101–104
   PubMedGoogle Scholar
• Hollier LM, Grissom H. Human herpes viruses in pregnancy: Cytomegalovirus, Epstein–Barr virus, and Vaicella zoster virus. Clin Perinatol 2005; 32: 671–696
   PubMedGoogle Scholar
• Xu F, Schillinger JA, Sternberg AR, Johnson RE, Lee FK, Nahmias AJ, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and 2 in the United States, 1988–1994. J Infect Dis 2002; 185: 1019–1024
   PubMed Web of Science ®Google Scholar
• National Center for Immunization and Respiratory Diseases. Annual Report Centers for Disease Control and Prevention, NIH 2008.
   Google Scholar
• Lopez A, Dietz VJ, Wilson F, Navin TR, Jones JL. Preventing congenital toxoplasmosis. CDC recommendations regarding selected conditions affecting women's health. MMWR 2000; 49(RQ-2RR-2): 57–74, available at www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm
   Google Scholar
• Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Phys 2003; 67: 2131–2138, 2145–2146
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii infection in the United States, 1999–2000. EID 2003; 9(11)1371–1374
   PubMedGoogle Scholar
• Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii in the United States: Seroprevalence and risk factors. AJE 2001; 154(4)357–365
   PubMed Web of Science ®Google Scholar
• Beazley DM, Egerman RS. Toxoplasmosis. Semin Perinatol 1998; 22(4)332–338
   PubMedGoogle Scholar
• Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. Am J Med 2005; 118: 212–216
   PubMed Web of Science ®Google Scholar
• Kaul R, Chen P, Binder SR. Detection of Immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections. J Clin Microbiol 2004; 42(12)5705–5709
   PubMedGoogle Scholar
• Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M. The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases-2008. IMAJ 2008; 10: 8–12
   Google Scholar
• Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital M. The mosaic of autoimmunity: Genetic factors involved in autoimmune diseases. IMAJ 2008; 10: 3–7
   Google Scholar
• Barzilai O, Sherer Y, Ram M, et al. Epstein–Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notorious? A preliminary report. Ann NY Acad Sci 2007; 1108: 567–577
   PubMed Web of Science ®Google Scholar
• Harley JB, James JA. Epstein–Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis 2006; 64(1–2)45–50
   PubMedGoogle Scholar
• James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein–Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019–3026
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger K. Epidemiology of multiple sclerosis: From risk factors to prevention. Semin Neurol 2008; 28: 17–28
   PubMed Web of Science ®Google Scholar
• Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y. The curiously sustpicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 2008, 30: 37–41
   PubMedGoogle Scholar
• Ascherio A, Munch M. Epstein–Barr virus and multiple sclerosis. Epidemiology 2000; 11: 220–224
   PubMed Web of Science ®Google Scholar
• Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms inmultiple sclerosis. JAMA 2005; 293: 2496–2500
   PubMed Web of Science ®Google Scholar
• James JA, Harley JB, Scofield RH. Epstein–Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 2006; 18: 462–467
   PubMed Web of Science ®Google Scholar
• Buka SL, Tsuang MT, Torrey EF, et al. Maternal infections and subsequent psychosis among offspring. Arch Gen Psych 2001; 58: 1032–1037
   PubMed Web of Science ®Google Scholar
• Early correlates of speech, language, and hearing, PJ LaBenz, ES LaBenz. PSG Publishing Co., Littleton, MA 1980
   Google Scholar
• Hardy JB, Shapiro S, Pathways to adulthood: A threegeneration urban study, 1960–1994: [Baltimore, Maryland]. Baltimore, MD: Johns Hopkins University, Department of Health Policy and Management [producers], 1998. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 1999. Available at http://www.niehs.nih.gov/research/atniehs/labs/epi/studies/dde/docs/cb2420tg-app.pdf
   Google Scholar
• Lawlor JP, Gladen E, Dhavale D, et al. Modernization and enhancement of the Collaborative Perinatal Project. The Johns Hopkins University, Baltimore, MD 2005, (195974 at ftp://sph-ftp.jhsph.edu (subdirectory∖cpp)). (Funded by the Stanley Medical Research Institute, Bethesda, MD, and National Institute of Mental Health Grant 070333)
   Google Scholar
• QUANTA Lite™. TPO for in vitro diagnostic use (Laboratory reference manual). INOVA Diagnostics, Inc., San Diego, CA 2003
   Google Scholar
• Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. l-Thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986; 9(4)299–305
   PubMedGoogle Scholar
• Karges B, Muche R, Knerr I, Ertelt W, Wiesel T, et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: A randomized, controlled trial. J Clin Endocrinol Metab 2007; 92: 1647–1652
   PubMed Web of Science ®Google Scholar
• Radon K, Dressel H, Windstetter D, Reichert J, Schmid M, Nowak D. Toxoplasma gondii infection, atopy and autoimmune disease. Eur J Med Res 2003; 8: 147–153
   PubMedGoogle Scholar
• Bach JF. The effect of infectionson susceptibility to autoimmune an allergic diseases. N Engl J Med 2002; 347: 911–920
   PubMed Web of Science ®Google Scholar
• Bach JF. Infections and autoimmune diseases. J Autoimmun 2005; 25: 74–80
   PubMed Web of Science ®Google Scholar
• Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MBA. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12(11)1301–1309
   PubMed Web of Science ®Google Scholar
• Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y. Infections and autoimmune thyroid diseases: Parallel detection of antibodies against pathogens with proteomic technology. Autoimmunity Rev 2008; 8: 112–115
   PubMed Web of Science ®Google Scholar
• Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000; 10: 871–887
   PubMedGoogle Scholar
• Glinoer D. Thyroid regulation and dysfunction in the pregnant patient. Chapter 14. Thyroid disease manager. Abbott Laboratories, Abbott Park, IL, Available at www.thyroidmanager.org/thyroidbook.htm (last updated April 4, 2006)
   Google Scholar
• Smyth PPA, Wijeyaratne CN, Kaluarachi WN, et al. Sequential studies on thyroid antibodies during pregnancy. Thyroid 2005; 15: 474–477
   PubMed Web of Science ®Google Scholar
• Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 2005; 38(3)247–255
   PubMed Web of Science ®Google Scholar
• Amital H, Gershwin ME, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum 2006; 35(6)341–343
   PubMedGoogle Scholar
• Zandman-Goddarda G, Shoenfeld Y. Infections and autoimmunity. Autoimmunity 2005; 38(7)473–485
   PubMedGoogle Scholar
• Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity 2006; 39(1)71–77
   PubMed Web of Science ®Google Scholar
• Stahl W, Kaneda Y. Impaired thyroid function in murine toxoplasmosis. Parasitology 1998; 117(3)217–222
   PubMedGoogle Scholar
• Stahl W, Kaneda Y. Aetiology of thyroidal dysfunction in murine toxoplasmosis. Parasitology 1998; 117(3)223–227
   PubMedGoogle Scholar
• Gazzinelli RT, Denkers EY. Protozoan encounters with toll-like receptor signaling pathways: Implications for host parasitism. Nat Rev Immunol 2006; 6(12)895–906
   PubMed Web of Science ®Google Scholar
• Yarovinsky F. Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol Lett 2008; 119: 17–21
   PubMedGoogle Scholar
• Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6(11)823–835
   PubMed Web of Science ®Google Scholar
• Mackay IR, Leskovsek NV, Rose NR. Cell damage and autoimmunity: A critical appraisal. J Autoimmun 2008; 30: 5–11
   PubMed Web of Science ®Google Scholar
• Laliberté J, Carruthers VB. Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 2008; 65: 1900–1915
   PubMed Web of Science ®Google Scholar